In the US, Mycophenolate Mofetil (mycophenolate mofetil systemic) is a member of the drug class selective immunosuppressants and is used to treat Autoimmune Hepatitis, Bullous Pemphigoid, Cogan's Syndrome, Crohn's Disease, Dermatomyositis, Evan's Syndrome, Graft-versus-host disease, High Cholesterol, Multiple Sclerosis, Myasthenia Gravis, Nephrotic Syndrome, Organ Transplant - Rejection Prophylaxis, Pemphigoid, Pemphigus, Pulmonary Fibrosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ulcerative Colitis and Uveitis.
US matches:
- Mycophenolate Mofetil
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Solution
- Mycophenolate Mofetil Suspension
- Mycophenolate mofetil Oral, Intravenous
UK matches:
- Mycophenolate Mofetil 250mg Capsules (SPC)
- Mycophenolate Mofetil 500mg Film-Coated Tablets (SPC)
- Mycophenolate Mofetil 500mg Tablets (SPC)
- Mycophenolate Mofetil Sandoz 250 mg capsules, hard (SPC)
Ingredient matches for Mycophenolate Mofetil
Mycophenolic Acid
Mycophenolate Mofetil (BANM, USAN) is known as Mycophenolic Acid in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment